• Ibrahim Almaghlouth, Tahera Islam, Nurah Alamro, Abdulrahman Alsultan, Assim Alfadda, Saleh Al-Muhsen, Abeer Almasry, Majid A Almadi, Ahmad Hersi, and Ahmed BaHammam.
• Department of Medicine, College of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia. E-mail. ialmaghlouth@ksu.edu.sa.
• Saudi Med J. 2020 Aug 1; 41 (8): 791801791-801.

AbstractTo map research production by Saudi-affiliated investigators in order to identify areas of strength and weakness. Method: We followed the Arksey and O'Malley (2005) framework. Medline and Cochrane databases were searched with a focus on identifying articles related to COVID-19 and Saudi Arabia following the PRISMA protocol. The study was conducted at King Saud University, Riyadh, Saudi Arabia between March and May 2020. Results: A total of 53 articles were ultimately included. Most of the research production from Saudi Arabia was opinion and narrative reviews related to the clinicopathological features of COVID-19 as well as control and prevention of virus spread.  Conclusion: The results of this scoping review identify a relative deficiency in original research, which requires further investigation.

14 keywords...

hide…